Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
<p>Abstract</p> <p>Recombinant Towne CMV expressing luciferase under the control of CMV-DNA polymerase (<it>POL</it>) or the late pp28 (UL99) promoters were evaluated for potential application in high-throughput screening of anti-viral compounds. <it>POL</it>...
Main Authors: | Posner Gary H, Burns William H, Hayward Gary S, Sandford Gordon, He Ran, Forman Michael, Arav-Boger Ravit |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/8/1/40 |
Similar Items
-
An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities.
by: Ran He, et al.
Published: (2011-01-01) -
Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.
by: Suchetha Murthy, et al.
Published: (2011-01-01) -
The Use of Artificial Neural Networks in Prediction of Congenital CMV Outcome from Sequence Data
by: Ravit Arav-Boger, et al.
Published: (2008-05-01) -
Cytomegalovirus (CMV) Infection and Latency
by: Christine M. O’Connor
Published: (2021-03-01) -
Challenges in Cytomegalovirus (CMV) Retinitis Management
by: Denisa Rosati, et al.
Published: (2019-09-01)